Latest BVF INC/IL Stock Portfolio

$3.91Billion | No. of Holdings #44

BVF INC/IL Performance

2026 Q2+24.55%

YTD+31.01%

2025+18.34%

About BVF INC/IL and 13F Hedge Fund Stock Holdings

On 2026-08-14, the fund reported it's updated stock portfolio. In the 13F Holdings report, BVF INC/IL reported an equity portfolio of $3.9 Billions as of 30 Jun, 2026. <br><br> The top stock holdings of BVF INC/IL are RVMD, KYMR, XOMA. The fund has invested 14.2% of it's portfolio in REVOLUTION MEDICINES INC and 11.3% of portfolio in KYMERA THERAPEUTICS INC. <br><br> The fund managers got completely rid off COMPASS THERAPEUTICS INC (CMPX), SEPTERNA INC and IMMUNIC INC (IMUX) stocks. They significantly reduced their stock positions in MIRUM PHARMACEUTICALS INC (MIRM), PALVELLA THERAPEUTICS INC NE and KYMERA THERAPEUTICS INC (KYMR). BVF INC/IL opened new stock positions in Q32 BIO INC, ABSCI CORPORATION (ABSI) and IMMUNIC INC (IMUX). The fund showed a lot of confidence in some stocks as they added substantially to XOMA ROYALTY CORPORATION (XOMA), ONKURE THERAPEUTICS INC and INVIVYD INC (ADGI).

BVF INC/IL Equity Portfolio Value

Last Reported on: 14 Aug, 2026

$3.91Billion

as of Aug 14, 2026

BVF INC/IL Annual Return Estimates Vs S&P 500

Our best estimate is that BVF INC/IL made a return of 24.55% in the last quarter. In trailing 12 months, it's portfolio return was 69.22%.

Performance
S&P 500

New Buys

Ticker	$ Bought
q32 bio inc	29,939,000
absci corporation	27,371,800
sagimet biosciences inc	19,325,000
immunic inc	11,762,600
research alliance corp iii	5,350,000
entera bio ltd	4,292,250
engene therapeutics	274,072

New stocks bought by BVF INC/IL

Additions

Ticker	% Inc.
xoma royalty corporation	193
onkure therapeutics inc	63.51
invivyd inc	44.25
avalo therapeutics inc	27.11
alkermes plc	7.74
revolution medicines inc	3.79

Additions to existing portfolio by BVF INC/IL

Reductions

Ticker	% Reduced
mirum pharmaceuticals inc	-33.36
palvella therapeutics inc ne	-29.99
kymera therapeutics inc	-29.63
tyra biosciences inc	-25.3
disc medicine inc	-9.33
nektar therapeutics	-6.58
structure therapeutics inc	-2.67
zymeworks inc	-2.28

BVF INC/IL reduced stake in above stock

Sold off

Ticker	$ Sold
compass therapeutics inc	-41,076,000
septerna inc	-32,518,600
engene holdings inc	-2,486,410
immunic inc	-8,494,800

BVF INC/IL got rid off the above stocks

Sector Distribution

BVF INC/IL has about 75.3% of it's holdings in Healthcare sector.

Healthcare
Others

Sector	%
Healthcare	75.3
Others	24

Market Cap. Distribution

BVF INC/IL has about 14.2% of it's portfolio invested in the large-cap and mega-cap stocks.

SMALL-CAP
UNALLOCATED
MID-CAP
LARGE-CAP
MICRO-CAP

Category	%
SMALL-CAP	37.4
UNALLOCATED	24
MID-CAP	21.7
LARGE-CAP	14.2
MICRO-CAP	2.7

Stocks belong to which Index?

About 62.5% of the stocks held by BVF INC/IL either belong to S&P 500 or RUSSELL 2000 index.

RUSSELL 2000
Others

Index	%
RUSSELL 2000	62.5
Others	37.5

Top 5 Winners (%)		%
GHRS	gh research plc	91.2 %
RVMD	revolution medicines inc	89.4 %
	anteris technologies global	77.5 %
GLUE	monte rosa therapeutics inc	47.1 %
ALKS	alkermes plc	45.7 %

Top 5 Winners ($)		$
RVMD	revolution medicines inc	262.1 M
KYMR	kymera therapeutics inc	147.1 M
GHRS	gh research plc	110.9 M
XOMA	xoma royalty corporation	56.7 M
ALKS	alkermes plc	35.4 M

Top 5 Losers (%)		%
IVA	inventiva sa	-31.9 %
ADGI	invivyd inc	-29.3 %
OLMA	olema pharmaceuticals inc	-16.1 %
TYRA	tyra biosciences inc	-14.5 %
ACIU	ac immune sa	-13.4 %

Top 5 Losers ($)		$
OLMA	olema pharmaceuticals inc	-12.7 M
TYRA	tyra biosciences inc	-11.0 M
ADGI	invivyd inc	-10.2 M
ACIU	ac immune sa	-7.3 M
NKTR	nektar therapeutics	-5.3 M

BVF INC/IL Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of BVF INC/IL

BVF INC/IL has 44 stocks in it's portfolio. About 65.6% of the portfolio is in top 10 stocks. OLMA proved to be the most loss making stock for the portfolio. RVMD was the most profitable stock for BVF INC/IL last quarter.

$3.91BTotal Value

48.00Positions

14 Aug, 2026Last Reported

Current holdings of Current Stock Holdings of BVF INC/IL, last reported on 14 Aug, 2026. Select a row with a linked ticker to view its historical trend.
Holdingsorted ascending	% Portfolio	Shares Held	$ Value	% Change
ABSI Absci Corporation Absci CorporationABSI BVF INC/IL's holding in Absci Corporation over time	0.7%	2,361,670	$27.37M 0.7%	new position

ACIU Ac Immune Sa Ac Immune Sa ACIU BVF INC/IL's holding in Ac Immune Sa over time	1.21%	19,822,400	$47.18M 1.21%	unchanged 0 percentunchanged

ADGI Invivyd Inc Invivyd IncADGI BVF INC/IL's holding in Invivyd Inc over time	0.63%	28,165,000	$24.57M 0.63%	increased 44.25 percentadded

ALKS Alkermes Plc Alkermes PlcALKS BVF INC/IL's holding in Alkermes Plc over time	2.89%	2,154,700	$112.90M 2.89%	increased 7.74 percentadded

ANNX Annexon Inc Annexon IncANNX BVF INC/IL's holding in Annexon Inc over time	1.27%	8,698,170	$49.67M 1.27%	unchanged 0 percentunchanged

AVTX Avalo Therapeutics Inc Avalo Therapeutics IncAVTX BVF INC/IL's holding in Avalo Therapeutics Inc over time	0.98%	2,075,540	$38.36M 0.98%	increased 27.11 percentadded

CGEM Cullinan Therapeutics Inc Cullinan Therapeutics IncCGEM BVF INC/IL's holding in Cullinan Therapeutics Inc over time	2.68%	5,750,680	$104.72M 2.68%	unchanged 0 percentunchanged

CMPX Compass Therapeutics Inc Compass Therapeutics IncCMPX BVF INC/IL's holding in Compass Therapeutics Inc over time	0%	0.00	$0.00 0%	decreased 100 percentsold off

ELDN Eledon Pharmaceuticals Inc Eledon Pharmaceuticals IncELDN BVF INC/IL's holding in Eledon Pharmaceuticals Inc over time	0.63%	6,293,280	$24.80M 0.63%	unchanged 0 percentunchanged

ENTX Entera Bio Ltd Entera Bio Ltd ENTX BVF INC/IL's holding in Entera Bio Ltd over time	0.11%	2,425,000	$4.29M 0.11%	new position

FDMT 4d Molecular Therapeutics In 4d Molecular Therapeutics InFDMT BVF INC/IL's holding in 4d Molecular Therapeutics In over time	0.98%	2,879,290	$38.29M 0.98%	unchanged 0 percentunchanged

FHTX Foghorn Therapeutics Inc Foghorn Therapeutics IncFHTX BVF INC/IL's holding in Foghorn Therapeutics Inc over time	0.73%	5,842,000	$28.51M 0.73%	unchanged 0 percentunchanged

GHRS Gh Research Plc Gh Research Plc GHRS BVF INC/IL's holding in Gh Research Plc over time	5.94%	8,650,160	$232.52M 5.94%	unchanged 0 percentunchanged

GLUE Monte Rosa Therapeutics Inc Monte Rosa Therapeutics IncGLUE BVF INC/IL's holding in Monte Rosa Therapeutics Inc over time	2.76%	4,460,890	$107.95M 2.76%	unchanged 0 percentunchanged

IKNA Imagenebio Inc Imagenebio IncIKNA BVF INC/IL's holding in Imagenebio Inc over time	0.17%	1,110,000	$6.55M 0.17%	unchanged 0 percentunchanged

IMCR Immunocore Hldgs Plc Immunocore Hldgs Plc IMCR BVF INC/IL's holding in Immunocore Hldgs Plc over time	1.05%	1,294,460	$41.10M 1.05%	unchanged 0 percentunchanged

IMUX Immunic Inc Immunic IncIMUX BVF INC/IL's holding in Immunic Inc over time	0.3%	765,295	$11.76M 0.3%	new position

IMUX Immunic Inc Immunic IncIMUX BVF INC/IL's holding in Immunic Inc over time	0%	0.00	$0.00 0%	decreased 100 percentsold off

IVA Inventiva Sa Inventiva Sa IVA BVF INC/IL's holding in Inventiva Sa over time	0.07%	686,040	$2.59M 0.07%	unchanged 0 percentunchanged

KURA Kura Oncology Inc Kura Oncology IncKURA BVF INC/IL's holding in Kura Oncology Inc over time	2.37%	8,445,770	$92.65M 2.37%	unchanged 0 percentunchanged

About BVF INC/IL and 13F Hedge Fund Stock Holdings

BVF INC/IL Annual Return Estimates Vs S&P 500

New Buys

Additions

Reductions

Sold off

Sector Distribution

Market Cap. Distribution

Stocks belong to which Index?

BVF INC/IL Holdings Map

Current Stock Holdings of BVF INC/IL

Ac Immune Sa

Entera Bio Ltd

Gh Research Plc

Immunocore Hldgs Plc

Inventiva Sa